Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-23-009529
Filing Date
2023-03-28
Accepted
2023-03-28 16:05:32
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B3 moonlake424b3.htm 424B3 2226306
2 orgstructureexhibit002a.jpg GRAPHIC 299247
3 pipelinea.jpg GRAPHIC 83983
4 prospectuscoverimage1a.jpg GRAPHIC 23577
5 pso_pasi100dataa.jpg GRAPHIC 155009
  Complete submission text file 0001628280-23-009529.txt   3001276
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262643 | Film No.: 23769509
SIC: 2834 Pharmaceutical Preparations